health - "medicine"

GPs are turning their backs on homeopathy, with the number of prescriptions for the alternative medicine falling by almost half.

California bans Trans Fat in all restaurants and eateries. Other states have single cities banning trans fats such as New York City, but California becomes the first state to ban trans fats throughout the entire state. Dr. Westby G. Fisher, MD, FACC, an Associate Professor of medicine at the Feinberg School of medicine, Northwestern University, Evanston, IL comments on trans fats.read more

Bayer's experimental anticoagulant Xarelto, its biggest new drug hope, has been recommended for approval by the European Medicines Agency.

Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial showed that Nexavar® (sorafenib) tablets decreased the absolute risk of death by 31 percent in patients with unresectable hepatocellular carcinoma (HCC), or liver cancer, versus patients who received placebo.

NHS Direct is delighted to have won the 2008 Ask About Medicines Award for 'Excellence in improving communication between healthcare professionals and patients or medicine users' for the Evelina Children's Hospital pilot Information Prescription project. During the pilot medicine prescriptions were used to trigger the offer of an information prescription from the Children's hospital and five community pharmacies across the country.

(NYU Langone Medical Center / New York University School of Medicine) NYU Langone Medical Center researchers have long been making important contributions to the understanding of Alzheimer's disease. They were among the first to characterize amyloid, the plaque-forming protein implicated in Alzheimer's, and the first to describe a genetic mutation in a familial form of the disease. They also developed the first successful intervention program to reduce the need for placing patients in nursing homes and alleviate caregivers' depression.

Scientists have developed a powerful new tool for genomic research and medicine -- a robust method for generating synthetic enzymes that can target particular DNA sequences for inactivation or repair.